7,304
Views
84
CrossRef citations to date
0
Altmetric
Research Paper

Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine

, , , , & ORCID Icon
Pages 2713-2722 | Received 11 May 2017, Accepted 29 Jul 2017, Published online: 10 Nov 2017

References

  • Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams A, Iskander J. CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR Morbidity Mortality Weekly Report. 2014;63(4):69-72. PMID:24476977
  • Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1-17. doi:10.1128/CMR.16.1.1-17.2003. PMID:12525422
  • Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, et al. Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)–associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175-201. doi: 10.1093/jnci/djs491
  • Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-4301. doi:10.1200/JCO.2011.36.4596. PMID:21969503
  • American Cancer Society. Cancer Statistics Center: Cancer Type – Cervix. 2017; https://cancerstatisticscenter.cancer.org/#/cancer-site/Cervix. (accessed 13 June 2017)
  • Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014. 2017. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/
  • Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA, Jr, Unger E. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63:1-30. PMID:25167164
  • Petrosky E, Bocchini JA, Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR. 2015;64:300-304. PMID:25811679
  • Angelo LB. Immunization update 2017. Pharmacy Today. 2017;23(5):56-64. doi:10.1016/j.ptdy.2017.04.029.
  • Palefsky JM. Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health. 2010;46(4 Suppl):S12-19. doi:10.1016/j.jadohealth.2010.01.010. PMID:20307839
  • Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morbidity Mortality Weekly Report. 2011;60(50):1705-1708. PMID:22189893
  • Reagan-Steiner S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2015. MMWR Morbidity Mortality Weekly Report. 2016;65:850-8. doi:10.15585/mmwr.mm6533a4. PMID:27561081
  • Rambout L, Tashkandi M, Hopkins L, Tricco AC. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: A systematic review. Prev Med. 2014;58(0):22-32. doi:10.1016/j.ypmed.2013.10.009. PMID:24176938
  • Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith J. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197-204. doi:10.1097/OLQ.0b013e3181f12dbf. PMID:20838362
  • Jacobson RM, Agunwamba AA, St Sauver JL, Finney Rutten LJ. The most effective and promising population health strategies to advance human papillomavirus vaccination. Expert Rev Vaccines. 2016;15(2):257-269. doi:10.1586/14760584.2016.1116947. PMID:26559567
  • Walling EB, Benzoni N, Dornfeld J, Bhandari R, Sisk BA, Garbutt J, Colditz G. Interventions to Improve HPV Vaccine Uptake: A Systematic Review. Pediatrics. 2016;138(1):e20153863. doi:10.1542/peds.2015-3863. PMID:27296865
  • Read DS, Joseph MA, Polishchuk V, Suss AL. Attitudes and perceptions of the HPV vaccine in Caribbean and African-American adolescent girls and their parents. J Pediatric Adolescent Gynecol. 2010;23(4):242-245. doi:10.1016/j.jpag.2010.02.002.
  • Cummings T, Kasting ML, Rosenberger JG, Rosenthal SL, Zimet GD, Stupiansky NW. Catching Up or Missing Out? Human Papillomavirus Vaccine Acceptability Among 18-to 26-Year-old men who have sex with men in a US National Sample. Sex Transm Dis. 2015;42(11):601-6doi:10.1097/OLQ.0000000000000358. PMID:26462183
  • Lai JY, Tinker AV, Cheung WY. Factors influencing the willingness of US women to vaccinate their daughters against the human papillomavirus to prevent cervical cancer. Medical Oncol. 2013;30(2):582. doi:10.1007/s12032-013-0582-z.
  • Licht AS, Murphy JM, Hyland AJ, Fix BV, Hawk LW, Mahoney MC. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sexually Transmitted Infect. 2010;86(1):74-78. doi:10.1136/sti.2009.037705.
  • Kontos EZ, Emmons KM, Puleo E, Viswanath K. Contribution of communication inequalities to disparities in human papillomavirus vaccine awareness and knowledge. Am J Public Health. 2012;102(10):1911-1920. doi:10.2105/AJPH.2011.300435. PMID:22970692
  • Kobetz E, Dunn Mendoza A, Menard J, Finney Rutten L, Diem J, Barton B, Kornfeld J, McKenzie N. One size does not fit all: differences in HPV knowledge between Haitian and African American women. Cancer Epidemiol Biomarkers Prev. 2010;19(2):366-370. doi:10.1158/1055-9965.EPI-09-1180. PMID:20142238
  • Patel PR, Berenson AB. Sources of HPV vaccine hesitancy in parents. Hum Vaccin Immunother. 2013;9(12):2649-2653. doi:10.4161/hv.26224. PMID:23982270
  • Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007;16(2):288-294. doi:10.1158/1055-9965.EPI-06-0756. PMID:17267388
  • Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007. Preventive Med. 2009;48(5):426-431. doi:10.1016/j.ypmed.2008.11.010.
  • Blake KD, Ottenbacher AJ, Finney Rutten LJ, Grady MA, Kobrin SC, Jacobson RM, Hesse B. Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Preventive Medi. 2015;48(4):402-410. doi:10.1016/j.amepre.2014.10.024.
  • Advisory Committee on Immunization Practices (ACIP). Summary Report. June 24–25, 2015. http://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-2015-06.pdf
  • Chesson HW, Laprise J-F, Brisson M, Markowitz LE. Impact and cost-effectiveness of 3 doses of 9-valent human papillomavirus (HPV) vaccine among US females previously vaccinated with 4-valent HPV vaccine. J Infect Dis. 2016;213(11):1694-1700. doi:10.1093/infdis/jiw046. PMID:26908738
  • Marlow LA, Zimet GD, McCaffery KJ, Ostini R, Waller J. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2013;31(5):763-769. doi:10.1016/j.vaccine.2012.11.083. PMID:23246310
  • Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006-2014–United States. MMWR Morbidity Mortal Wkly Rep. 2014;63(29):620-624
  • Palefsky JM. Human papillomavirus-related disease in men: not just a women's issue. J Adolescent Health. 2010;46(4):S12-S19. doi:10.1016/j.jadohealth.2010.01.010.
  • Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(S10):3036-3046. doi:10.1002/cncr.23764. PMID:18980286
  • Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol. 2013;31(12):1569-75. doi:10.1200/JCO.2012.45.2524. PMID:23509304
  • Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, Tobo BB, Geneus CJ, Schootman M. Not just a woman's business! Understanding men and women's knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev Med. 2017;99:299-304. doi:10.1016/j.ypmed.2017.03.014. PMID:28341458
  • Vanderpool RC, Dressler EV, Stradtman LR, Crosby RA. Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women. J Rural Health. Spring 2015;31(2):199-205. doi:10.1111/jrh.12102. PMID:25640763
  • Reiter PL, Katz ML, Paskett ED. Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate. Vaccine. 2013;31(31):3121-3125. doi:10.1016/j.vaccine.2013.04.068. PMID:23664990
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76-82. doi:10.1001/jamapediatrics.2013.2752. PMID:24276343
  • Paskett ED, Krok-Schoen JL, Pennell ML, Tatum CM, Reiter PL, Peng J, Bernardo BM, Weier RC, Richardson MS, Katz ML. Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls. Cancer Epidemiol Biomarkers Prev. 2016;25(4):593-602. doi:10.1158/1055-9965.EPI-15-1243. PMID:27196093
  • Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith J. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197-204. doi:10.1097/OLQ.0b013e3181f12dbf. PMID:20838362
  • Grandahl M, Oscarsson M, Stenhammar C, Neveus T, Westerling R, Tyden T. Not the right time: why parents refuse to let their daughters have the human papillomavirus vaccination. Acta paediatrica (Oslo, Norway: 1992). 2014;103(4):436-441. doi:10.1111/apa.12545. PMID:24460679
  • Krawczyk A, Knauper B, Gilca V, Dubé E, Perez S, Joyal-Desmarais K, Rosberger Z. Parents' decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results. Hum Vaccin Immunother. 2015;11(2):322-329. doi:10.1080/21645515.2014.1004030. PMID:25692455
  • Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45(5):528-531. doi:10.1016/j.jadohealth.2009.02.006. PMID:19837361
  • Perez S, Tatar O, Shapiro GK, Dubé E, Ogilvie G, Guichon J, Gilca V, Rosberger Z. Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study. BMC Public Health. 2016;16(1):1223. doi:10.1186/s12889-016-3828-9. PMID:27919239
  • Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health. 2013;103(1):164-169. doi:10.2105/AJPH.2011.300600. PMID:22698055
  • Mohammed KA, Geneus CJ, Osazuwa-Peters N, Adjei Boakye E, Tobo BB, Burroughs TE. Disparities in provider recommendation of human papillomavirus vaccination for US adolescents. J Adolescent Health. 2016;59(5):592-598. doi:10.1016/j.jadohealth.2016.06.005
  • Osazuwa-Peters N, Wang DD, Namin A, John VM, O'Neill M, Patel PV, Varvares M. Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group. Oral Oncol. 2015;51(5):452-456. doi:10.1016/j.oraloncology.2015.01.011. PMID:25683135
  • Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine. 2011;29(47):8634-8641. doi:10.1016/j.vaccine.2011.09.006. PMID:21924315
  • Bailey HH, Chuang LT, duPont NC, Eng C, Foxhall LE, Merrill JK, Wollins DS, Blanke CD. American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention. J Clin Oncol. 2016;34(15):1803-1812. doi:10.1200/JCO.2016.67.2014. PMID:27069078
  • Saslow D, Andrews KS, Manassaram‐Baptiste D, Loomer L, Lam KE, Fisher-Borne M, Smith RA, Fontham ET. Human papillomavirus vaccination guideline update: American Cancer Society Guideline endorsement. CA. 2016;66(5):375-8. PMID:27434803
  • Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(3):896-908. doi:10.1093/ije/dyt049. PMID:23620381
  • Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis. 2011;204(3):372-376. doi:10.1093/infdis/jir285. PMID:21742835
  • Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016;137(3):e20151968. doi:10.1542/peds.2015-1968. PMID:26908697
  • Tarney C, Pagan M, Klaric J, Beltran T, Han J. HPV Vaccination Does Not Provide Herd Immunity for Unvaccinated Women or Cross-Protection for Nonvaccine HPV Types [12].Obstetrics and gynecology. 2016;127 Suppl 1:4s
  • U.S. Department of Health and Human Services. Healthy People 2020 topics & objectives: immunization and infectious diseases. 2013; https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives
  • Osazuwa-Peters N. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States–do we need a broader vaccine policy? Vaccine. 2013;31(47):5500-5505. doi:10.1016/j.vaccine.2013.09.031. PMID:24095883
  • Keim-Malpass J, Mitchell EM, DeGuzman PB, Stoler MH, Kennedy C. Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy. Risk Management Healthcare Policy. 2017;10:29-32. doi:10.2147/RMHP.S128247. PMID:28331378
  • Hirsch JA, Rosenkrantz AB, Nicola GN, Harvey HB, Duszak R, Jr, Silva E, 3rd, Barr RM, Klucznik RP, Brook AL, Manchikanti L. Contextualizing the first-round failure of the AHCA: down but not out. J Neurointerventional Surg. 2017;9(6):595-600. doi:10.1136/neurintsurg-2017-013136.
  • Cantor D. CK, Crystal-Mansour S, Davis T, Dipko S, Sigman R. Health Information National Trends Survey (HINTS) 2007: Final report. Rockville, MD: Westat; 2009.
  • Fahimi M, Link M, Mokdad A, Schwartz DA, Levy P. Tracking chronic disease and risk behavior prevalence as survey participation declines: statistics from the behavioral risk factor surveillance system and other national surveys. Preventing Chronic Dis. 2008;5(3):A80
  • National Cancer Institute. Health Information National Trends Survey. 2014; http://hints.cancer.gov/hints4.aspx. Accessed October 10, 2015
  • Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000–2014. NCHS Data Brief. 2016;232:1-8
  • NCFMR Family Profiles. Fatherhood in the U.S.: Men's Age at First Birth, 1987–2010 https://www.bgsu.edu/content/dam/BGSU/college-of-arts-and-sciences/NCFMR/documents/FP/FP-11-04.pdf. Accessed 10/8/2016

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.